Jackson Square Partners LLC Purchases New Holdings in Healthequity Inc (NASDAQ:HQY)

Jackson Square Partners LLC purchased a new position in shares of Healthequity Inc (NASDAQ:HQY) in the 1st quarter, HoldingsChannel.com reports. The institutional investor purchased 1,737,284 shares of the company’s stock, valued at approximately $128,524,000.

Several other hedge funds also recently bought and sold shares of the stock. Signaturefd LLC boosted its holdings in shares of Healthequity by 24.3% during the first quarter. Signaturefd LLC now owns 803 shares of the company’s stock worth $59,000 after purchasing an additional 157 shares during the period. Oregon Public Employees Retirement Fund raised its position in Healthequity by 0.9% during the first quarter. Oregon Public Employees Retirement Fund now owns 21,721 shares of the company’s stock valued at $1,607,000 after acquiring an additional 190 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Healthequity by 5.9% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,953 shares of the company’s stock valued at $236,000 after acquiring an additional 220 shares in the last quarter. Global Retirement Partners LLC raised its position in Healthequity by 72.7% during the first quarter. Global Retirement Partners LLC now owns 556 shares of the company’s stock valued at $41,000 after acquiring an additional 234 shares in the last quarter. Finally, RMB Capital Management LLC raised its position in Healthequity by 0.5% during the fourth quarter. RMB Capital Management LLC now owns 50,933 shares of the company’s stock valued at $3,038,000 after acquiring an additional 252 shares in the last quarter. Institutional investors and hedge funds own 96.06% of the company’s stock.

Several equities analysts recently weighed in on HQY shares. KeyCorp raised their price objective on shares of Healthequity from $74.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, March 19th. Zacks Investment Research raised shares of Healthequity from a “sell” rating to a “hold” rating in a research report on Wednesday, February 13th. Oppenheimer raised their price objective on shares of Healthequity from $74.00 to $98.00 and gave the company an “outperform” rating in a research report on Tuesday, March 19th. BidaskClub raised shares of Healthequity from a “buy” rating to a “strong-buy” rating in a research report on Saturday, March 16th. Finally, Bank of America reaffirmed a “neutral” rating and set a $82.00 price objective (up previously from $67.00) on shares of Healthequity in a research report on Friday, March 1st. Three investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $86.25.



Shares of NASDAQ:HQY traded down $1.52 during trading on Wednesday, reaching $68.38. The stock had a trading volume of 21,695 shares, compared to its average volume of 890,972. Healthequity Inc has a 52 week low of $50.29 and a 52 week high of $101.58. The firm has a market cap of $4.25 billion, a price-to-earnings ratio of 71.87, a P/E/G ratio of 2.64 and a beta of 1.55. The company has a quick ratio of 15.59, a current ratio of 15.60 and a debt-to-equity ratio of 0.07.

Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Monday, March 18th. The company reported $0.21 EPS for the quarter, beating the Zacks’ consensus estimate of $0.15 by $0.06. Healthequity had a net margin of 30.60% and a return on equity of 14.17%. The company had revenue of $75.78 million for the quarter, compared to analyst estimates of $74.28 million. During the same quarter last year, the firm posted $0.09 earnings per share. The company’s quarterly revenue was up 25.4% compared to the same quarter last year. Research analysts predict that Healthequity Inc will post 1.01 EPS for the current fiscal year.

In other news, VP Darcy G. Mott sold 4,000 shares of Healthequity stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $68.17, for a total value of $272,680.00. Following the transaction, the vice president now owns 64,100 shares of the company’s stock, valued at $4,369,697. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In the last three months, insiders sold 12,000 shares of company stock worth $876,200. Insiders own 3.70% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Jackson Square Partners LLC Purchases New Holdings in Healthequity Inc (NASDAQ:HQY)” was originally published by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://dakotafinancialnews.com/2019/06/12/jackson-square-partners-llc-purchases-new-holdings-in-healthequity-inc-nasdaqhqy.html.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading: What Are Cryptocurrencies?

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.